GLOFITAMAB
UNII 06P3KLK2J8

Substance Identification & Data

This profile provides standardized clinical and technical data for Glofitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 06P3KLK2J8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2229047-91-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
06P3KLK2J8
CAS Registry Number
2229047-91-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GLOFITAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
06P3KLK2J8
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11145
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
HI-119
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Glofitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GLOFITAMAB
GLOFITAMAB-GXBM

Common Names & Synonyms

ANTI-CD20/CD3 BISPECIFIC MONOCLONAL ANTIBODY RO7082859
GLOFITAMAB [INN]
GLOFITAMAB [USAN]
GLOFITAMAB [WHO-DD]
GLOFITAMAB GXBM [WHO-DD]

Brand / Trade Names

COLUMVI

Technical Codes

RG-6026
RO7082859
RO-7082859

NDC Products Containing GLOFITAMAB

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: